145 related articles for article (PubMed ID: 37436769)
41. Gene-specific differences in the circadian variation of ventricular repolarization in the long QT syndrome: a key to sudden death during sleep?
Stramba-Badiale M; Priori SG; Napolitano C; Locati EH; Viñolas X; Haverkamp W; Schulze-Bahr E; Goulene K; Schwartz PJ
Ital Heart J; 2000 May; 1(5):323-8. PubMed ID: 10832806
[TBL] [Abstract][Full Text] [Related]
42. Use of Artificial Intelligence and Deep Neural Networks in Evaluation of Patients With Electrocardiographically Concealed Long QT Syndrome From the Surface 12-Lead Electrocardiogram.
Bos JM; Attia ZI; Albert DE; Noseworthy PA; Friedman PA; Ackerman MJ
JAMA Cardiol; 2021 May; 6(5):532-538. PubMed ID: 33566059
[TBL] [Abstract][Full Text] [Related]
43. Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long QT syndrome.
Shimizu W; Noda T; Takaki H; Nagaya N; Satomi K; Kurita T; Suyama K; Aihara N; Sunagawa K; Echigo S; Miyamoto Y; Yoshimasa Y; Nakamura K; Ohe T; Towbin JA; Priori SG; Kamakura S
Heart Rhythm; 2004 Sep; 1(3):276-83. PubMed ID: 15851169
[TBL] [Abstract][Full Text] [Related]
44. Sodium channel blockers in the management of long QT syndrome types 3 and 2: A system review and meta-analysis.
Yang Y; Lv TT; Li SY; Zhang P
J Cardiovasc Electrophysiol; 2021 Nov; 32(11):3057-3067. PubMed ID: 34427958
[TBL] [Abstract][Full Text] [Related]
45. Utility of treadmill testing in identification and genotype prediction in long-QT syndrome.
Wong JA; Gula LJ; Klein GJ; Yee R; Skanes AC; Krahn AD
Circ Arrhythm Electrophysiol; 2010 Apr; 3(2):120-5. PubMed ID: 20071715
[TBL] [Abstract][Full Text] [Related]
46. Arrhythmia risk and β-blocker therapy in pregnant women with long QT syndrome.
Ishibashi K; Aiba T; Kamiya C; Miyazaki A; Sakaguchi H; Wada M; Nakajima I; Miyamoto K; Okamura H; Noda T; Yamauchi T; Itoh H; Ohno S; Motomura H; Ogawa Y; Goto H; Minami T; Yagihara N; Watanabe H; Hasegawa K; Terasawa A; Mikami H; Ogino K; Nakano Y; Imashiro S; Fukushima Y; Tsuzuki Y; Asakura K; Yoshimatsu J; Shiraishi I; Kamakura S; Miyamoto Y; Yasuda S; Akasaka T; Horie M; Shimizu W; Kusano K
Heart; 2017 Sep; 103(17):1374-1379. PubMed ID: 28292826
[TBL] [Abstract][Full Text] [Related]
47. Follow-up of 316 molecularly defined pediatric long-QT syndrome patients: clinical course, treatments, and side effects.
Koponen M; Marjamaa A; Hiippala A; Happonen JM; Havulinna AS; Salomaa V; Lahtinen AM; Hintsa T; Viitasalo M; Toivonen L; Kontula K; Swan H
Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):815-23. PubMed ID: 26063740
[TBL] [Abstract][Full Text] [Related]
48. Genotype Predicts Outcomes in Fetuses and Neonates With Severe Congenital Long QT Syndrome.
Moore JP; Gallotti RG; Shannon KM; Bos JM; Sadeghi E; Strasburger JF; Wakai RT; Horigome H; Clur SA; Hill AC; Shah MJ; Behere S; Sarquella-Brugada G; Czosek R; Etheridge SP; Fischbach P; Kannankeril PJ; Motonaga K; Landstrom AP; Williams M; Patel A; Dagradi F; Tan RB; Stephenson E; Krishna MR; Miyake CY; Lee ME; Sanatani S; Balaji S; Young ML; Siddiqui S; Schwartz PJ; Shivkumar K; Ackerman MJ
JACC Clin Electrophysiol; 2020 Nov; 6(12):1561-1570. PubMed ID: 33213816
[TBL] [Abstract][Full Text] [Related]
49. Clinical and genetic profile of congenital long QT syndrome in Hong Kong: a 20-year experience in paediatrics.
Kwok SY; Liu AP; Chan CY; Lun KS; Fung JL; Mak CC; Chung BH; Yung TC
Hong Kong Med J; 2018 Dec; 24(6):561-570. PubMed ID: 30530868
[TBL] [Abstract][Full Text] [Related]
50. Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry.
Locati EH; Zareba W; Moss AJ; Schwartz PJ; Vincent GM; Lehmann MH; Towbin JA; Priori SG; Napolitano C; Robinson JL; Andrews M; Timothy K; Hall WJ
Circulation; 1998 Jun; 97(22):2237-44. PubMed ID: 9631873
[TBL] [Abstract][Full Text] [Related]
51. Genetic variant annotation scores in congenital long QT syndrome.
Younis A; Bodurian C; Arking DE; Bragazzi NL; Tabaja C; Zareba W; McNitt S; Aktas MK; Polonsky B; Lopes CM; Sotoodehnia N; Kudenchuk PJ; Goldenberg I
Ann Noninvasive Electrocardiol; 2023 Sep; 28(5):e13080. PubMed ID: 37571804
[TBL] [Abstract][Full Text] [Related]
52. Long QT syndrome in patients over 40 years of age: increased risk for LQTS-related cardiac events in patients with coronary disease.
Sze E; Moss AJ; Goldenberg I; McNitt S; Jons C; Zareba W; Qi M; Robinson JL;
Ann Noninvasive Electrocardiol; 2008 Oct; 13(4):327-31. PubMed ID: 18973489
[TBL] [Abstract][Full Text] [Related]
53. Frequency and severity of hypoglycemia in children with beta-blocker-treated long QT syndrome.
Poterucha JT; Bos JM; Cannon BC; Ackerman MJ
Heart Rhythm; 2015 Aug; 12(8):1815-9. PubMed ID: 25929701
[TBL] [Abstract][Full Text] [Related]
54. Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome.
Shimizu W; Antzelevitch C
J Am Coll Cardiol; 2000 Mar; 35(3):778-86. PubMed ID: 10716483
[TBL] [Abstract][Full Text] [Related]
55. Epinephrine-induced QT interval prolongation: a gene-specific paradoxical response in congenital long QT syndrome.
Ackerman MJ; Khositseth A; Tester DJ; Hejlik JB; Shen WK; Porter CB
Mayo Clin Proc; 2002 May; 77(5):413-21. PubMed ID: 12004990
[TBL] [Abstract][Full Text] [Related]
56. Epinephrine QT stress testing in the evaluation of congenital long-QT syndrome: diagnostic accuracy of the paradoxical QT response.
Vyas H; Hejlik J; Ackerman MJ
Circulation; 2006 Mar; 113(11):1385-92. PubMed ID: 16534005
[TBL] [Abstract][Full Text] [Related]
57. Pediatric Cohort With Long QT Syndrome - KCNH2 Mutation Carriers Present Late Onset But Severe Symptoms.
Ozawa J; Ohno S; Hisamatsu T; Itoh H; Makiyama T; Suzuki H; Saitoh A; Horie M
Circ J; 2016; 80(3):696-702. PubMed ID: 26823142
[TBL] [Abstract][Full Text] [Related]
58. Clinical Aspects of Type 3 Long-QT Syndrome: An International Multicenter Study.
Wilde AA; Moss AJ; Kaufman ES; Shimizu W; Peterson DR; Benhorin J; Lopes C; Towbin JA; Spazzolini C; Crotti L; Zareba W; Goldenberg I; Kanters JK; Robinson JL; Qi M; Hofman N; Tester DJ; Bezzina CR; Alders M; Aiba T; Kamakura S; Miyamoto Y; Andrews ML; McNitt S; Polonsky B; Schwartz PJ; Ackerman MJ
Circulation; 2016 Sep; 134(12):872-82. PubMed ID: 27566755
[TBL] [Abstract][Full Text] [Related]
59. Mexiletine Shortens the QT Interval in Patients With Potassium Channel-Mediated Type 2 Long QT Syndrome.
Bos JM; Crotti L; Rohatgi RK; Castelletti S; Dagradi F; Schwartz PJ; Ackerman MJ
Circ Arrhythm Electrophysiol; 2019 May; 12(5):e007280. PubMed ID: 31006312
[TBL] [Abstract][Full Text] [Related]
60. Single nucleotide polymorphisms in arrhythmia genes modify the risk of cardiac events and sudden death in long QT syndrome.
Earle N; Yeo Han D; Pilbrow A; Crawford J; Smith W; Shelling AN; Cameron V; Love DR; Skinner JR
Heart Rhythm; 2014 Jan; 11(1):76-82. PubMed ID: 24096169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
